(100 Percent Fed Up) Could this be a game-changer as Omicron spreads across the United States? A milestone in the fight against the pandemic as the first at-home treatment Covid-19 treatment gets FDA authorization.
Related FDA Should Need Only ‘12 Weeks’ to Release Pfizer Data, Not 75 Years, Plaintiff Calculates
by Staff Writer, December 22nd, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset.
In clinical trials, Pfizer’s treatment reduced the risk of hospitalization and death by 89 percent when taken three days after the onset of symptoms. Individuals eligible for the pill need a prescription and should begin taking the treatment as soon as possible within five days of the start of symptoms, the FDA said in a statement Wednesday. The FDA said the Pfizer pill is not a substitute for vaccination in individuals eligible for Covid-19 shots and boosters.
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”
Paxlovid is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in those requiring hospitalization due to severe or critical COVID-19. Paxlovid is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended, the FDA said.
Emergency Use Authorization is different than FDA approval. At this stage, the agency has determined that the known and potential benefits of Paxlovid, when used consistent with the terms and conditions of the authorization, outweigh the known and potential risks. The FDA also said that at this time, there are no adequate, approved, and available alternatives to Paxlovid for the treatment of COVID-19.
The safety and effectiveness of Paxlovid for the treatment of COVID-19 continue to be evaluated, the FDA said.
The federal government has already purchased 10 million doses of Pfizer’s pill and will begin delivering them over the next several months.
FDA authorizes Pfizer oral antiviral COVID-19 treatmenthttps://t.co/syWtYsr9Xe
— FOX Business (@FoxBusiness) December 22, 2021
Not surprisingly, U.S. stocks picked up momentum in afternoon trading after the Food and Drug Administration approved Pfizer’s COVID-19 pill for use in adults and children ages 12 and older.
Stillness in the Storm Editor: Why did we post this?
The news is important to all people because it is where we come to know new things about the world, which leads to the development of more life goals that lead to life wisdom. The news also serves as a social connection tool, as we tend to relate to those who know about and believe the things we do. With the power of an open truth-seeking mind in hand, the individual can grow wise and the collective can prosper.
– Justin
Not sure how to make sense of this? Want to learn how to discern like a pro? Read this essential guide to discernment, analysis of claims, and understanding the truth in a world of deception: 4 Key Steps of Discernment – Advanced Truth-Seeking Tools.
Stillness in the Storm Editor’s note: Did you find a spelling error or grammatical mistake? Send an email to [email protected], with the error and suggested correction, along with the headline and url. Do you think this article needs an update? Or do you just have some feedback? Send us an email at [email protected]. Thank you for reading.
Source:
https://100percentfedup.com/breaking-fda-gives-green-light-to-pfizers-antiviral-covid-19-pill/
Support our work! (Avoid Big Tech PayPal and Patreon)DIRECT DONATION
Leave a Reply